Additionally, the TAK1 inactivation by the inhibitor 5Z7 (5Z-7-oxozeaenol) improved the efficiency of the treatment with Taxol (paclitaxel) in ovarian cancer cells. The gene discussed is MAP3K7; the disease is ovarian carcinoma.